1. Assessing the Risk for Stroke in Patients With Atrial Fibrillation

2. Learning Objectives

3. The Burden Of Atrial Fibrillation

4. Prevalence of AF Is Substantial and Expected to Grow

5. Atrial Fibrillation And Stroke

6. ROCKET-AF Stroke Risk in Paroxysmal AF

7. CHA2DS2-VASc Risk of Stroke in Patients With AF

8. GARFIELD-AF Increasing CHA2DS2-VASc Score Predicts Poor Outcomes

9. GARFIELD-AF Increasing HAS-BLED Score Predicts Poor Outcomes

10. AHA/ACC/HRS Guidelines Anticoagulation Recommendations for Patients With Nonvalvular AF

11. ORBIT-AF Physician Assessment of Stroke Risk vs CHADS2 Score

12. GARFIELD-AF Evolving Antithrombotic Treatment Patterns

13. GARFIELD-AF Global Patterns in NOAC Uptake

14. GARFIELD-AF Event Rates According to Renal Function*

15. ORBIT-AF Causes of Hospitalization

16. GARFIELD-AF Reasons for Not Providing VKA*

17. Registry of the Canadian Stroke Network Most High-Risk Patients With AF Who Have a Stroke Were Not Receiving Guideline-Recommended Therapy

18. Anticoagulant Use Reduces Stroke Risk in Patients With AF

19. GARFIELD-AF Event Rates According to TTR

20. Challenges in AF-Related Stroke Management

21. Abbreviations

22. Abbreviations (cont)

23. References

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)